Ramesh Pooja, Srikumar Saranya, Mahendran Vimaladhithan, Nair Sobha S, Radhamany K
1Department of Obstetrics and Gynaecology, Amrita Institute of Medical Science, Kochi, Kerala India.
2Department of General Surgery, Amrita Institute of Medical Science, Kochi, Kerala India.
J Obstet Gynaecol India. 2019 Dec;69(6):514-519. doi: 10.1007/s13224-019-01249-9. Epub 2019 Jul 18.
The number of cancers diagnosed during pregnancy is on the rise, and breast cancer is the most common malignancy. Presently, there are very limited resources and no clear guidelines for managing this peculiar patient population both worldwide and in India. The objective of this study was to find out the incidence of pregnancy-associated breast cancer (PABC) in a tertiary care referral centre and to compare the epidemiological, diagnostic and prognostic factors as well as maternal and foetal outcomes with the most recent literature worldwide.
We conducted a retrospective descriptive study of women diagnosed with breast cancer in pregnancy and post-partum period at a tertiary care centre in southern India during the period of 10 years (total number of breast cancer patients were 10). We studied the diagnostic and prognostic factors as well as maternal and foetal outcome in patients diagnosed with breast cancer for the first time in pregnancy.
Overall incidence of PABC was found to be 0.6% ( = 10). Mean age at the time of presentation was 30.7 ± 4 years. All cases suspected clinically or on imaging (USG) were confirmed with FNAC, excision biopsy or Trucut biopsy. Out of 10 patients, 70% ( = 7) had an advanced-stage disease on diagnosis. Histopathology suggested 90% ( = 9) had invasive ductal carcinoma and 55.5% ( = 5) had a triple negative receptor status. 20% ( = 2) of our patients had opted for a breast conservation surgery (BCS), and 70% ( = 7) of our patients underwent modified radical mastectomy with neoadjuvant or adjuvant chemotherapy/radiotherapy. One patient had a second trimester MTP in view of stage 4 disease. 77.7% ( = 7) of the nine patients who continued pregnancy underwent LSCS, out of which 57.4% ( = 4) were elective, and MRM was done concurrently with LSCS in 50% ( = 2) of the elective LSCS. The mean birth weight of the 9 neonates was 2.2 ± 0.5 kg. Intrauterine growth retardation was seen in 22.2% ( = 2) neonates. 33.3% ( = 3) of the neonates required NICU support, and one baby expired on post-natal day 16.
With the increasing number of elderly primigravida amongst the urban population, a clear understanding of PABC is becoming more important. A multidisciplinary team approach shall help the clinician not only in reducing the heavy burden of patient responsibility but more importantly, in guaranteeing better quality of treatment, avoiding unnecessary delays in providing interventions and providing adequate treatment.
孕期诊断出的癌症数量呈上升趋势,乳腺癌是最常见的恶性肿瘤。目前,全球和印度在管理这一特殊患者群体方面资源非常有限,且没有明确的指导方针。本研究的目的是在一家三级医疗转诊中心找出妊娠相关乳腺癌(PABC)的发病率,并将其流行病学、诊断和预后因素以及母婴结局与全球最新文献进行比较。
我们对印度南部一家三级医疗中心10年间在孕期和产后被诊断为乳腺癌的女性进行了一项回顾性描述性研究(乳腺癌患者总数为10例)。我们研究了首次在孕期被诊断为乳腺癌的患者的诊断和预后因素以及母婴结局。
发现PABC的总体发病率为0.6%(n = 10)。就诊时的平均年龄为30.7±4岁。所有临床怀疑或影像学检查(超声)怀疑的病例均通过细针穿刺抽吸活检(FNAC)、切除活检或粗针活检得以确诊。10例患者中,70%(n = 7)在诊断时患有晚期疾病。组织病理学显示,90%(n = 9)为浸润性导管癌,55.5%(n = 5)为三阴性受体状态。我们的患者中有20%(n = 2)选择了保乳手术(BCS),70%(n = 7)的患者接受了改良根治性乳房切除术并辅以新辅助或辅助化疗/放疗。鉴于处于4期疾病,1例患者在孕中期进行了引产。继续妊娠的9例患者中有77.7%(n = 7)接受了低位剖宫产术(LSCS),其中57.4%(n = 4)为选择性剖宫产,在50%(n = 2)的选择性LSCS中,改良根治性乳房切除术与LSCS同时进行。9例新生儿的平均出生体重为2.2±0.5千克。22.2%(n = 2)的新生儿出现宫内生长迟缓。33.3%(n = 3)的新生儿需要新生儿重症监护病房(NICU)的支持,1名婴儿在出生后第16天死亡。
随着城市人口中高龄初产妇数量的增加,对PABC的清晰认识变得越发重要。多学科团队方法不仅有助于临床医生减轻沉重的患者责任负担,更重要的是,有助于保证更高的治疗质量,避免在提供干预措施时出现不必要的延误,并提供充分的治疗。